Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874223 · ClinicalTrials.gov registry record
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 40
- Enrollment target
NCT01874223: Completed study, sponsored by Stanford University.
NCT01874223 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01874223 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to test cough, dyspnea (shortness of breath), and quality of life (QOL) questionnaires for their accuracy, sensitivity, and ability to reliably measure the severity of cough, breathlessness, and changes in cough and disease-related quality of life over time in Idiopathic Pulmonary Fibrosis (IPF) patients. These questionnaires have been used in other types of disease, but have not all been tested and validated in patients with cough due to IPF. Our hypothesis is that worsening of cough, dyspnea, and cough-related QOL questionnaire scores will correlate with physiologic markers of IPF severity and worsening of disease. Written, valid questionnaires measuring cough, dyspnea, and QOL are important to assess the benefit of investigational drugs under development to treat patients with IPF.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-11-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01874223
The ClinicalTrials.gov registry entry for NCT01874223 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01874223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01874223 about?
NCT01874223 is a clinical study titled "Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF". The purpose of this study is to test cough, dyspnea (shortness of breath), and quality of life (QOL) questionnaires for their accuracy, sensitivity, and ability to reliably measure the severity of cough, breathlessness, and changes in cough and disease-related quality of life over time in Idiopathic...
What is the current status of trial NCT01874223?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-06. Estimated completion is 2018-11-04.
Who is sponsoring clinical trial NCT01874223?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.